FERRARI, Silvia Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.218
EU - Europa 2.466
AS - Asia 619
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
AF - Africa 3
Totale 8.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.198
GB - Regno Unito 1.430
SE - Svezia 256
CN - Cina 236
DE - Germania 213
UA - Ucraina 165
TR - Turchia 164
IT - Italia 122
FI - Finlandia 108
HK - Hong Kong 102
FR - Francia 73
SG - Singapore 68
BG - Bulgaria 62
VN - Vietnam 15
ID - Indonesia 12
RU - Federazione Russa 11
BZ - Belize 9
CA - Canada 9
IE - Irlanda 9
MY - Malesia 7
NL - Olanda 5
AU - Australia 4
BR - Brasile 4
CL - Cile 4
JP - Giappone 4
EG - Egitto 3
EU - Europa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BE - Belgio 2
ES - Italia 2
IN - India 2
IR - Iran 2
PK - Pakistan 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CH - Svizzera 1
CR - Costa Rica 1
EC - Ecuador 1
HU - Ungheria 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
MX - Messico 1
NP - Nepal 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.324
Salva come PNG Salva come JPEG
Città #
Southend 1.275
Fairfield 911
Woodbridge 589
Ashburn 442
Jacksonville 386
Houston 345
Seattle 332
Chandler 296
Cambridge 282
Wilmington 246
Dearborn 225
Ann Arbor 217
Nyköping 184
Izmir 113
Hong Kong 102
Beijing 79
Princeton 70
San Diego 65
Bremen 62
Sofia 62
Eugene 58
Modena 55
Helsinki 51
Singapore 45
London 41
Los Angeles 34
Des Moines 25
New York 25
Shanghai 18
Redwood City 17
Frankfurt am Main 15
Atlanta 14
Dong Ket 14
San Jose 14
Boardman 12
Norwalk 12
Chiswick 11
Hefei 11
Jakarta 11
Milan 11
Hounslow 10
Kunming 10
Belize City 9
Dublin 9
Kilburn 9
Mountain View 6
Phoenix 6
Saint Louis 6
Acton 5
Falls Church 5
Guangzhou 5
Indiana 5
Nanjing 5
Toronto 5
Chicago 4
Jinan 4
Saint Petersburg 4
San Francisco 4
Verona 4
Chengdu 3
Dallas 3
Edinburgh 3
Groningen 3
Hangzhou 3
Islington 3
Jiaxing 3
Leawood 3
Prescot 3
Serra 3
Shenyang 3
Bologna 2
Brussels 2
Cairo 2
Columbus 2
Dongguan 2
Ferrara 2
Frattamaggiore 2
Fuzhou 2
Gunzenhausen 2
Inverno e Monteleone 2
Nonantola 2
Nürnberg 2
Raleigh 2
Rho 2
Rome 2
Serpukhov 2
Stockholm 2
Sydney 2
São Paulo 2
Turin 2
Warsaw 2
Wuxi 2
Yellow Springs 2
Zhengzhou 2
Alghero 1
Anzola Dell'emilia 1
Baltimore 1
Baotou 1
Bari 1
Berlin 1
Totale 6.979
Salva come PNG Salva come JPEG
Nome #
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 691
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 280
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 195
Cytokines and HCV-Related Disorders. 194
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 187
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 181
New targeted molecular therapies for dedifferentiated thyroid cancer 180
Associations between Systemic Sclerosis and Thyroid Diseases 176
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 173
Endocrine manifestations of hepatitis C virus infection. 160
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 155
IP-10 in autoimmune thyroiditis 152
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 152
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 151
Novel Therapies for Thyroid Autoimmune Diseases 150
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 148
CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis 147
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 145
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 145
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 142
High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10 140
HEPATITIS C IS ASSOCIATED WITH HIGH LEVELS OF CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND INTERLEUKIN-6 140
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. 138
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 137
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 136
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 135
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 135
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 134
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 132
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. 131
CXCL10 in psoriasis 126
RET TKI: potential role in thyroid cancers. 125
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. 125
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 123
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 121
Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. 120
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 119
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 119
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 119
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 119
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 118
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 113
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 110
Role of CXCL10 in cryoglobulinemia 104
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 103
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 102
[CXCR3 and CXCL10 in autoimmune thyroiditis] 100
Interleukin-1beta, C-X-C Motif Ligand 10, and Interferon-Gamma Serum Levels in Mixed Cryoglobulinemia With or Without Autoimmune Thyroiditis. 99
[Cryoglobulinemia and the α-chemokine IP-10] 96
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 90
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 90
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 90
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 88
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia 86
Extrahepatic manifestations of hepatitis C virus: the thyroid disorders 85
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 82
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine 80
HCV-related autoimmune disorders in HCV chronic infection. 79
Hepatitis C virus infection and type 2 diabetes. 71
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia 69
Mixed cryoglobulinemia and thyroid autoimmune disorders 69
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience 38
Totale 8.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.991 201 98 49 117 187 340 303 277 186 64 100 69
2020/20211.811 129 52 116 146 154 222 175 329 86 167 151 84
2021/20221.135 53 154 194 68 8 55 72 41 96 90 190 114
2022/2023980 153 76 81 74 151 139 19 103 110 7 45 22
2023/2024640 12 37 38 120 158 25 45 62 12 37 31 63
2024/202540 40 0 0 0 0 0 0 0 0 0 0 0
Totale 8.440